Hot Flashes and Panic Attacks: A Comparison of Symptomatology, Neurobiology, Treatment, and a Role for Cognition

Psychological Bulletin

Volumn 134, Issue 2, 2008, Pages 247-269

  Hanisch, Laura J ^a   Hantsoo, Liisa ^a   Freeman, Ellen W ^a   Sullivan, Gregory M ^b   Coyne, James C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Och Spine at New York Presbyterian Hospitals

Author keywords

anxiety sensitivity; hormones; hot flash; panic; sternal skin conductance

Indexed keywords

ARTICLE; DRUG THERAPY; ESTROGEN THERAPY; FEMALE; HOT FLUSH; HUMAN; METABOLISM; METHODOLOGY; MIDDLE AGED; PANIC; PSYCHOLOGICAL ASPECT;

DRUG THERAPY; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; PANIC DISORDER;

EID: 40749119633     PISSN: 00332909     EISSN: None     Source Type: Journal    
DOI: 10.1037/0033-2909.134.2.247     Document Type: Article

References (291)

1. Abelson J.L., Curtis G.C., and Uhde T.W. Twenty-four hour growth hormone secretion in patients with panic disorder. Psychoneuroendocrinology 30 1 (2005) 72-79
2. Albertsen P.C., Aaronson N.K., Muller M.J., Keller S.D., and Ware J.E. Health-related quality of life among patients with metastatic prostate cancer. Urology 49 2 (1997) 207-216
3. American Psychiatric Association. Diagnostic and statistical manual for mental disorders. 4th ed. (1994), Author, Washington, DC
4. Antony M.M., Brown T.A., Craske M.G., Barlow D.H., Mitchell W.B., and Meadows E.A. Accuracy of heartbeat perception in panic disorder, social phobia, and nonanxious subjects. Journal of Anxiety Disorders 9 (1995) 355-371
5. Arntz A., and van den Hout M. Psychological treatments of panic disorder without agoraphobia: Cognitive therapy versus applied relaxation. Behaviour Research and Therapy 34 2 (1996) 113-121
6. Avis N.E., Crawford S.L., and McKinlay S.M. Psychosocial, behavioral, and health factors related to menopause symptomatology. Women's Health 3 2 (1997) 103-120
7. Bakker A., van Balkom A.J.L.M., and Spinhoven P. SSRIs vs. TCAs in the treatment of panic disorder: A meta-analysis. Acta Psychiatrica Scandinavica 106 (2002) 163-167
8. Bakker A., van Balkom A.J.L.M., Spinhoven P., Blaauw B.M.J.W., and van Dyck R. Follow-up on the treatment of panic disorder with or without agoraphobia: A quantitative review. Journal of Nervous and Mental Disorders 186 (1998) 414-419
9. Ballenger J.C., Wheadon D.E., Steiner M., Bushnell W., and Gergel I.P. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. American Journal of Psychiatry 155 1 (1998) 36-42
10. Barlow D.H. Anxiety and its disorders: The nature and treatment of anxiety disorders (1988), Guilford Press, New York
11. Başoĝlu M., Marks I.M., and Şengün S. A prospective study of panic and anxiety in agoraphobia with panic disorder. British Journal of Psychiatry 160 (1992) 57-64
12. Beck J.G., Stanley M.A., Baldwin L.E., Deagle E.A., and Averill P.M. Comparison of cognitive therapy and relaxation training for panic disorder. Journal of Consulting and Clinical Psychology 62 4 (1994) 818-826
13. Berendsen H.H.G. The role of serotonin in hot flushes. Maturitas 36 (2000) 155-164
14. Bertani A., Perna G., Migliarese G., Di Pasquale D., Cucchi M., Caldirola D., et al. Comparison of the treatment with paroxetine and reboxetine in panic disorder: A randomized, single-blind study. Pharmacopsychiatry 37 5 (2004) 206-210
15. Boshuisen M.L., Slaap B.R., Vester-Blokland E.D., and den Boer J.A. The effect of mirtazapine in panic disorder: An open label pilot study with a single blind placebo run-in period. International Clinical Psychopharmacology 16 6 (2001) 363-368
16. Bradwejn J., Ahokas A., Stein D.J., Salinas E., Emilien G., and Whitaker T. Venlaflaxine extended-release capsules in panic disorder: Flexible-dose, double-blind, placebo-controlled study. British Journal of Psychiatry 187 (2005) 352-359
17. Brady K.T., Lydiard R.B., Ballenger J.C., Shook J., Laraia M., and Fossey M. CSF opioids in panic disorder. Biological Psychiatry 30 5 (1991) 512-514
18. Brambilla F., Biggio G., Pisu M.G., Bellodi L., Perna G., Bogdanovich-Djukic V., et al. Neurosteroid secretion in panic disorder. Psychiatry Research 118 2 (2003) 107-116
19. Brambilla F., Mellado C., Alciati A., Pisu M.G., Purdy R.H., Zonone S., et al. Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder. Psychiatry Research 135 (2005) 185-190
20. Briggs A.C., Stretch D.D., and Brandon S. Subtyping of panic disorder by symptom profile. British Journal of Psychiatry 163 (1993) 201-209
21. Brown W.J., Mishra G.D., and Dobson A. Changes in physical symptoms during the menopause transition. International Journal of Behavioral Medicine 9 1 (2002) 53-67
22. Bruce S.E., Yonkers K.A., Otto M.W., Eisen J.L., Weisberg R.B., Pagano M., et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study. American Journal of Psychiatry 162 (2005) 1179-1187
23. Bystritsky A., Craske M., Maidenberg E., Vapnik T., and Shapiro D. Ambulatory monitoring of panic patients during regular activity: A preliminary report. Biological Psychiatry 38 10 (1995) 684-689
24. 2 inhalation procedure. Depression and Anxiety 11 (2000) 15-26
25. Bystritsky A., Pontillo D., Powers M., Sabb F.W., Craske M.G., and Bookheimer S.Y. Functional MRI changes during panic anticipation and imagery exposure. NeuroReport 12 18 (2001) 3953-3957
26. Cagnacci A., Melis G.B., Soldani R., Paoletti A.M., Gambacciani M., Spinetti A., et al. Neuroendocrine and clinical effects of transdermal 17 beta-estradiol in postmenopausal women. Maturitas 13 4 (1991) 283-296
27. Caldirola D., Bellodi L., Caumo A., Migliarese G., and Perna G. Approximate entropy of respiratory patterns in panic disorder. American Journal of Psychiatry 161 1 (2004) 79-87
28. Cameron O.G., Smith C.B., Nesse R.M., Hill E.M., Hollingsworth P.J., Abelson J.A., et al. Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives. Psychosomatic Medicine 58 4 (1996) 289-301
29. Carlson P.J., Neumeister A., Geraci M., Kaplan J., Nugent A., Luckenbaugh D., et al. Noradrenergic mechanisms in panic disorder: Behavioral, autonomic, and neurophysiological correlates of a yohimbine challenge. Biological Psychiatry 59 8, Suppl. 1 (2006) 167S
30. Carmody J., Crawford S., and Churchill L. A pilot study of mindfulness-based stress reduction for hot flashes. Menopause: The Journal of The North American Menopause Society 13 5 (2006) 760-769
31. Carpenter J.S., Andrykowski M.A., Freedman R.R., and Munn R. Feasibility and psychometrics of an ambulatory hot flash monitoring device. Menopause 6 3 (1999) 209-215
32. Carpenter J.S., Johnson D., Wagner L., and Andrykowski M. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncology Nursing Forum Online 29 (2002) 16-25
33. Carpenter J.S., Storniolo A.M., Johns S., Monahan P.O., Azzouz F., Elam J.L., et al. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. The Oncologist 12 (2007) 124-135
34. Casper R.F., and Yen S.S.C. Menopausal flushes: Effect of pituitary gonadotropin desensitization by a potent luteinizing-hormone-releasing factor agonist. Journal of Clinical Endocrinology & Metabolism 53 5 (1981) 1056-1058
35. Casper R.F., and Yen S.S. Neuroendocrinology of menopausal flushes: An hypothesis of flush mechanism. Clinical Endocrinology 22 3 (1985) 293-312
36. Casper R.F., Yen S.S., and Wilkes M.M. Menopausal flushes: A neuroendocrine link with pulsatile luteninizing hormone secretion. Science 205 4408 (1979, August 24) 823-825
37. Charney D.S., Woods S.W., Krystal J.H., Nagy L.M., and Heninger G.R. Noradrenergic neuronal dysregulation in panic disorder: The effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatrica Scandinavica 86 4 (1992) 273-282
38. Chung C.K., Remington N.D., and Suh B.Y. Estrogen replacement therapy may reduce panic symptoms. Journal of Clinical Psychiatry 56 11 (1995) 533
39. Cignarelli M., Cincinelli E., Corso M., Cospite M.R., Garruti G., Giogino R., et al. Biophysical and endocrine-metabolic changes during menopausal hot flashes: Increase in plasma free fatty acid and norepinephrine levels. Gynecologic and Obstetric Investigation 27 1 (1989) 34-37
40. Clark D.M. A cognitive approach to panic. Behaviour Research and Therapy 24 (1986) 461-470
41. Clark D.M., and Ehlers A. An overview of the cognitive theory and treatment of panic disorder. Applied and Preventive Psychology 2 (1993) 131-139
42. Clark, D. M. & Salkovskis, P. M. (in press). Panic disorder. In K. Hawton, P. M. Salkovskis, J. Kirk, & D. M. Clark (Eds.), Cognitive behaviour therapy: A practical guide (2nd ed.). Oxford, England: Oxford University Press.
43. Cohen L.S., Sichel D.A., Faraone S.V., Robertson L.M., Dimmock J.A., and Rosenbaum J.F. Course of panic disorder during pregnancy and the puerperium: A preliminary study. Biological Psychiatry 39 11 (1996) 950-954
44. Coplan J.D., Liebowitz M.R., Gorman J.M., Fyer A.J., Dillon D.J., Campeas R.B., et al. Noradrenergic function in panic disorder. Effects of intravenous clonidine pretreatment on lactate induced panic. Biological Psychiatry 31 (1992) 135-146
45. Coplan J.D., Papp L.A., Pine D., Martinez J., Cooper T., Rosenblum L.A., et al. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Archives of General Psychiatry 54 (1997) 643-648
46. Coplan J.D., Pine D., Papp L., Martinez J., Cooper T., Rosenblum L.A., et al. Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patients. Neuropsychopharmacology 13 1 (1995) 65-73
47. Coryell W., Dindo L., Fyer A., and Pine D.S. Onset of spontaneous panic attacks: A prospective study of risk factors. Psychosomatic Medicine 68 (2006) 754-757
48. 2 challenge. A study in panic disorder patients and healthy volunteers. European Psychiatry 20 (2005) 299-303
49. Crandall C.J., Crawford S.L., and Gold E.B. Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors. The American Journal of Medicine 119 (2006) S52-S60
50. Craske M.G., Brown T.A., and Barlow D.H. Behavioral treatment of panic disorder: A two-year follow-up. Behavioral Therapy 22 3 (1991) 289-304
51. Dager S.R., Cowley D.S., Dorsa D.M., and Dunner D.L. Plasma beta-endorphin response to lactate infusion. Biological Psychiatry 25 (1989) 243-245
52. Dager S.R., Richards T., Strauss W., and Artru A. Single-voxel H-1-MRS investigation of brain metabolic changes during lactate-induced panic. Psychiatry Research: Neuroimaging 76 2-3 (1997) 89-99
53. Dannon P.N., Iancu I., Lowengrub K., Grunhaus L., and Kotler M. Recurrence of panic disorder during pregnancy: A 7-year naturalistic follow-up study. Clinical Neuropharmacology 29 3 (2006) 132-137
54. Deacon B.J., and Abramowitz J.S. Cognitive and behavioral treatments for anxiety disorders: A review of meta-analytic findings. Journal of Clinical Psychology 60 4 (2004) 429-441
55. de Bakker I.P.M., and Everaerd W. Measurement of menopausal hot flushes: Validation and cross-validation. Maturitas 25 (1996) 87-98
56. de Beurs E., Chambless D.L., and Goldstein A.J. Measurement of panic disorder by a modified panic diary. Depression and Anxiety 6 (1997) 133-139
57. de Beurs E., Garssen B., Bouikhuisen M., Lange A., van Balkom A., and van Dyck R. Continuous monitoring of panic. Acta Psychiatrica Scandinavica 90 (1994) 38-45
58. DeFazio J., Verheugen C., Chetkowski R., Nass T., Judd H.L., and Meldrum D.R. The effects of naloxone on hot flashes and gonadotropin secretion in postmenopausal women. Journal of Clinical Endocrinology & Metabolism 58 3 (1984) 578-581
59. Dembert M.L., Dinneen M.P., and Opsahl M.S. Estrogen-induced panic disorder. American Journal of Psychiatry 151 8 (1994) 1246
60. Dennerstein L., Smith A.M.A., Morse C., Burger H., Green A., Hopper J., et al. Menopausal symptoms in Australian women. The Medical Journal of Australia 159 (1993) 232-236
61. Eaton W.W., Kessler R.C., Wittchen H.U., and Magee W.J. Panic and panic disorder in the United States. American Journal of Psychiatry 151 3 (1994) 413-420
62. Ehlers A. Interoception and panic disorder. Advances in Behaviour Research and Therapy 15 (1993) 3-21
63. Ehlers A., and Breuer P. Increased cardiac awareness in panic disorder. Journal of Abnormal Psychology 101 (1992) 371-382
64. Ehlers A., and Breuer P. How good are patients with panic disorder at perceiving their heartbeats?. Biological Psychology 42 (1996) 165-182
65. Ehlers A., Breuer P., Dohn D., and Fiegenbaum W. Heartbeat perception and panic disorder: Possible explanations for discrepant findings. Behaviour Research and Therapy 33 (1995) 69-76
66. Eriksson E., Westberg P., Thuresson K., Modigh K., Ekman R., and Widerlov E. Increased cerebrospinal fluid levels of endorphin immunoreactivity in panic disorder. Neuropsychopharmacology 2 3 (1989) 225-228
67. Eser D., Schüle C., Romeo E., Baghai T.C., di Michele F., Pasini A., et al. Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders. Psychopharmacology 186 (2006) 373-387
68. Finck G., Barton D.L., Loprinzi C.L., Quella S.K., and Sloan J.A. Definitions of hot flashes in breast cancer survivors. Journal of Pain & Symptom Management 16 5 (1998) 327-333
69. Ford K., Sowers M., Crutchfield M., Wilson A., and Jannausch M. A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause. Menopause 12 3 (2005) 308-317
70. Forsyth J.P., Eifert G.H., and Canna M.A. Evoking analogue subtypes of panic attacks in a nonclinical population using carbon dioxide-enriched air. Behaviour Research and Therapy 38 (2000) 559-572
71. Freedman R.R. Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology 26 5 (1989) 573-579
72. Freedman R.R. Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertility & Sterility 70 2 (1998) 332-337
73. Freedman R.R. Menopausal hot flashes. In: Lobo R.A., Kelsey J., and Marcus R. (Eds). Menopause: Biology and pathobiology (2000), Academic Press, San Diego, CA 215-227
74. Freedman R.R., Benton M.D., Genik R.J., and Graydon F.X. Cortical activation during menopausal hot flashes. Fertility & Sterility 85 3 (2006) 674-678
75. Freedman R.R., and Blacker C.M. Estrogen raises the sweating threshold in postmenopausal women with hot flashes. Fertility & Sterility 77 3 (2002) 487-490
76. Freedman R.R., and Dinsay R. Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertility & Sterility 74 1 (2000) 20-23
77. Freedman R.R., Ianni P., Ettedgui E., and Puthezhath N. Ambulatory monitoring of panic disorder. Archives of General Psychiatry 42 3 (1985) 244-248
78. Freedman R.R., and Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. American Journal of Obstetrics & Gynecology 181 1 (1999) 66-70
79. Freedman R.R., Norton D., Woodward S., and Cornelissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. Journal of Clinical Endocrinology & Metabolism 80 8 (1995) 2354-2358
80. Freedman R.R., and Woodward S. Behavioral treatment of menopausal hot flushes: Evaluation by ambulatory monitoring. American Journal of Obstetrics & Gynecology 167 2 (1992) 436-439
81. Freedman R.R., and Woodward S. Elevated alpha2-adrenergic responsiveness in menopausal hot flashes: Pharmacologic and biochemical studies. In: Lomax P., and Schönbaum E. (Eds). Thermoregulation: The pathophysiological basis of clinical disorders (1992), Karger, Basel, Switzerland 6-9
82. Freedman R.R., and Woodward S. Biochemical and thermoregulatory effects of behavioral treatment for menopausal hot flashes. Menopause 2 (1995) 211-218
83. Freedman R.R., and Woodward S. Core body temperature during menopausal hot flushes. Fertility & Sterility 65 (1996) 1141-1144
84. Freedman R.R., Woodward S., and Norton D.A.M. Laboratory and ambulatory monitoring of menopausal hot flushes: Comparison of symptomatic and asymptomatic women. Journal of Psychophysiology 6 (1992) 162-166
85. Freedman R.R., Woodward S., and Sabharwal S.C. Alpha 2-adrenergic mechanism in menopausal hot flushes. Obstetrics & Gynecology 76 4 (1990) 573-578
86. Freeman E.W., Sammel M.D., Grisso J.A., Battistini M., Garcia-Espagna B., and Hollander L. Hot flashes in the late reproductive years: Risk factors for African American and Caucasian women. Journal of Women's Health & Gender-Based Medicine 10 1 (2001) 67-76
87. Freeman E.W., Sammel M.D., Lin H., Gracia C.R., Kapoor S., and Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause: The Journal of the North American Menopause Society 12 3 (2005) 258-266
88. Freeman E.W., Sammel M.D., Rinaudo P.J., and Sheng L. Premenstrual syndrome as a predictor of menopausal symptoms. Obstetrics & Gynecology 103 5 (2004) 960-966
89. Gallicchio L., Visvanathan K., Miller S.R., Babus J., Lewis L.M., Zacur H., et al. Body mass, estrogen levels, and hot flashes in midlife women. American Journal of Obstetrics & Gynecology 193 (2005) 1353-1360
90. Gannon L., Hansel S., and Goodwin J. Correlates of menopausal hot flashes. Journal of Behavioral Medicine 10 (1987) 277-285
91. Garssen B., Buikhuisen M., and van Dyck R. Hyperventilation and panic attacks. American Journal of Psychiatry 153 (1996) 513-518
92. Geller P.A., Klier C.M., and Neugebauer R. Anxiety disorders following miscarriage. Journal of Clinical Psychiatry 62 6 (2001) 432-438
93. Genazzani A.R., Petraglia F., Facchinetti F., Facchini V., Volpe A., and Alessandrini G. Increase of proopiomelanocortin-related peptides during subjective menopausal flushes. American Journal of Obstetrics & Gynecology 149 7 (1984) 775-779
94. George D.T., Adinoff B., Ravitz B., Nutt D.J., De Jong J., Berrettini W., et al. A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism. Acta Psychiatrica Scandinavica 82 1 (1990) 1-7
95. Geraci M., Anderson T.S., Slate-Cothren S., Post R.M., and McCann U.D. Pentagastrin-induced sleep panic attacks: Panic in the absence of elevated baseline arousal. Biological Psychiatry 52 12 (2002) 1183-1189
96. Gerber L.M., Sievert L.L., Warren K., Pickering T.G., and Schwartz J.E. Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause 14 (2007) 308-315
97. Germaine L.M., and Freedman R.R. Behavioral treatment of menopausal hot flashes: Evaluation by objective methods. Journal of Consulting and Clinical Psychology 52 6 (1984) 1072-1079
98. Ginsburg E.S., Mello N.K., Mendelson J.H., Barbieri R.L., Teoh S.K., Rothman M., et al. Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA: The Journal of the American Medical Association 276 21 (1996) 1747-1751
99. Ginsburg J., Swinhoe J., and O'Reilly B. Cardiovascular responses during the menopausal hot flush. British Journal of Obstetrics & Gynaecology 88 (1981) 925-930
100. Goetz R.R., Klein D.F., Gully R., Kahn J., Liebowitz M.R., Fyer A.J., et al. Panic attacks during placebo procedures in the laboratory: Physiology and symptomatology. Archives of General Psychiatry 50 4 (1993) 280-285
101. Gold E.B., Block G., Crawford S., Lachance L., FitzGerald G., Miracle H., et al. Lifestyle and demographic factors in relation to vasomotor symptoms: Baseline results from the Study of Women's Health Across the Nation. American Journal of Epidemiology 159 (2004) 1189-1199
102. Gold E.B., Colvin A., Avis N., Bromberger J., Greendale G.A., Powell L., et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of women's health across the nation. American Journal of Public Health 96 7 (2006) 1226-1235
103. Gold E.B., Sternfeld B., Kelsey J.L., Brown C., Mouton C., Reame N., et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. American Journal of Epidemiology 152 (2000) 463-473
104. Goodwin R.D., Fergusson D.M., and Horwood L.J. Childhood abuse and familial violence and the risk of panic attacks and panic disorder in young adulthood. Psychological Medicine 35 (2005) 881-890
105. Goodwin R.D., Lewinsohn P.M., and Seeley J.R. Respiratory symptoms and mental disorders among youth: Results from a prospective, longitudinal study. Psychosomatic Medicine 66 (2004) 943-949
106. Gordon C.J., Rowsey P.J., and Yang Y. Effect of repeated nicotine exposure on core temperature and motor activity in male and female rats. Journal of Thermal Biology 27 (2002) 485-492
107. Gordon P.R., Kerwin J.P., Boesen K.G., and Senf J. Sertraline to treat hot flashes: A randomized controlled, double-blind, crossover trial in a general population. Menopause: The Journal of the North American Menopause Society 13 4 (2006) 568-575
108. Gorman J.M., Garakani A., Martinez J., Aaronson C., and Buchsbaum M. Regional metabolic brain activation in patients with panic disorder during doxapram infusion. Neuropsychopharmacology 30 Suppl. 1 (2005) S21
109. Gorman J.M., Kent J.M., Sullivan G.M., and Coplan J.D. Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry 157 (2000) 493-505
110. Gould R.A., Otto M.W., and Pollack M.H. A meta-analysis of treatment outcome for panic disorder. Clinical Psychology Review 15 (1995) 819-844
111. Gracia C.R., Sammel M.D., Freeman E.W., Lin H., Langan E., Kapoor S., et al. Defining menopause status: Creation of a new definition to identify the early changes of the menopausal transition. Menopause: The Journal of the North American Menopause Society 12 2 (2005) 128-135
112. Grady D., Cohen B., Tice J., Kristof M., Olyaie A., and Sawaya G.F. Ineffectiveness of sertraline for treatment of menopausal hot flushes: A randomized controlled trial. Obstetrics & Gynecology 109 (2007) 823-830
113. Graeff F.G., Garcia-Leal C., Del-Ben C.M., and Guimaraes F.S. Does the panic attack activate the hypothalamic-pituitary-adrenal axis?. Anais Da Academia Brasileira De Ciencias 77 3 (2005) 477-491
114. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., Goldstein R.B., Smith S., et al. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 67 3 (2006) 363-374
115. Grisso J.A., Freeman E.W., Maurin E., Garcia-Espana B., and Berlin J.A. Racial differences in menopause information and the experience of hot flashes. Journal of General Internal Medicine 14 (1999) 98-103
116. Gurguis G.N.M., Antai-Otong D., Vo S.P., Blakeley J.E., Orsulak P.J., Petty F., et al. Adrenergic receptor function in panic disorder: I. Platelet alpha(2) receptors: G(i) protein coupling, effects of imipramine, and relationship to treatment outcome. Neuropsychopharmacology 20 2 (1999) 162-176
117. Gurguis G.N.M., Turkka J., George D.T., and Linnoila M. Beta-adrenoreceptor coupling to G(s) protein in alcohol dependence, panic disorder, and patients with both conditions. Neuropsychopharmacology 16 1 (1997) 69-76
118. Guthrie J.R., Dennerstein L., Hopper J.L., and Burger H.G. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstetrics & Gynecology 88 3 (1996) 437-442
119. Guthrie J.R., Dennerstein L., Taffe J.R., and Donnelly V. Health care-seeking for menopausal problems. Climacteric 6 (2003) 112-117
120. Guthrie J.R., Dennerstein L., Taffe J.R., Lehert P., and Burger H.G. Hot flushes during the menopause transition: A longitudinal study in Australian-born women. Menopause 12 4 (2005) 460-467
121. Guttuso Jr. T., Kurlan R., McDermott M.P., and Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: A randomized controlled trial. Obstetrics & Gynecology 101 2 (2003) 337-345
122. Hahn P.M., Wong J., and Reid R.L. Menopausal-like hot flashes reported in women of reproductive age. Fertility & Sterility 70 5 (1998) 913-918
123. Hammar M., Ekblad S., Lonnberg B., Berg G., Lindgren R., and Wyon Y. Postmenopausal women without previous or current vasomotor symptoms do not flush after abruptly abandoning estrogen replacement therapy. Maturitas 31 2 (1999) 117-122
124. Hanisch L.J., Mao J.J., Kodransky M., and Coyne J.C. Opioid withdrawal as a cause of hot flushing remains hypothetical. The Lancet 367 9505 (2006) 92-93
125. Hanisch L.J., Palmer S.C., Donahue A., and Coyne J.C. Validation of sternal skin conductance for detection of hot flashes in prostate cancer survivors. Psychophysiology 44 (2007) 189-193
126. Hardy R., and Kuh D. Change in psychological and vasomotor symptom reporting during the menopause. Social Science & Medicine 55 (2002) 1975-1988
127. Harlow B.L., Wise L.A., Otto M.W., Soares C.N., and Cohen L.S. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: The Harvard Study of Moods and Cycles. Archives of General Psychiatry 60 (2003) 29-36
128. Hasler G., Gergen P.J., Kleinbaum D.G., Ajdacic V., Gamma A., Eich D., et al. Asthma and panic in young adults: A 20-year prospective community study. American Journal of Respiratory and Critical Care Medicine 171 (2005) 1224-1230
129. Hayward C., Killen J.D., Kraemer H.C., and Taylor C.B. Predictors of panic attacks in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 39 2 (2000) 207-214
130. Hibbert G.A., and Pilsbury D. Hyperventilation in panic attacks: Ambulant monitoring of transcutaneous carbon dioxide. British Journal of Psychiatry 153 (1988) 76-80
131. Ho H.P., Westberg L., Annerbrink K., Olsson M., Melke J., Nilsson S., et al. Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women. Psychoneuroendocrinology 29 9 (2004) 1138-1141
132. Hoehn-Saric R., McLeod D.R., Funderburk F., and Kowalski P. Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: An ambulatory monitor study. Archives of General Psychiatry 61 9 (2004) 913-921
133. Hunter M.S., Grunfeld E.A., Mittal S., Sikka P., Ramirez A.J., Fentiman I., et al. Menopausal symptoms in women with breast cancer: Prevalence and treatment preferences. Psycho-Oncology 13 11 (2004) 769-778
134. Hunter M.S., and Liao K.L. Determinants of treatment choice for menopausal hot flushes: Hormonal versus psychological versus no treatment. Journal of Psychosomatic Obstetrics & Gynecology 16 2 (1995) 101-108
135. Hunter M.S., and Liao K.L. A psychological analysis of menopausal hot flushes. British Journal of Clinical Psychology 34 (1995) 589-599
136. Hunter M.S., and Liao K.L.M. Evaluation of a four-session cognitive-behavioural intervention for menopausal hot flushes. British Journal of Health Psychology 1 (1996) 113-125
137. Hvas L., Thorsen H., and Søndergaard K. Discussing menopause in general practice. Maturitas 46 (2003) 139-146
138. Irvin J.H., Domar A.D., Clark C., Zuttermeister P.C., and Friedman R. The effects of relaxation response training on menopausal symptoms. Journal of Psychosomatic Obstetrics & Gynecology 17 4 (1996) 202-207
139. Isensee B., Wittchen H.U., Stein M.B., Hofler M., and Lieb R. Smoking increases the risk of panic: Findings from a prospective community study. Archives of General Psychiatry 60 7 (2003) 692-700
140. James G.D., Sievert L.L., and Flanagan E. Ambulatory blood pressure and heart rate in relation to hot flash experience among women of menopausal age. Annals of Human Biology 31 1 (2004) 49-58
141. Javanmard M., Shlik J., Kennedy S.H., Vaccarino F.J., Houle S., and Bradwejn J. Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: A comparison of two time points. Biological Psychiatry 45 7 (1999) 872-882
142. Kaspi S.P., Otto M.W., Pollack M.H., Eppinger S., and Rosenbaum J.F. Premenstrual exacerbation of symptoms in women with panic disorder. Journal of Anxiety Disorders 8 2 (1994) 131-138
143. Keefer L., and Blanchard E.B. A behavioral group treatment program for menopausal hot flashes: Results of a pilot study. Applied Psychophysiology and Biofeedback 30 1 (2005) 21-30
144. Kenardy J., Fried L., Kraemer H.C., and Taylor B. Psychological precursors of panic attacks. British Journal of Psychiatry 160 (1992) 668-673
145. Kenardy J., and Taylor C.B. Expected versus unexpected panic attacks: A naturalistic prospective study. Journal of Anxiety Disorders 13 (1999) 435-445
146. Keogh E., Dillon C., Georgiou G., and Hunt C. Selective attentional biases for physical threat in physical anxiety sensitivity. Anxiety Disorders 15 (2001) 299-315
147. Kerwin J.P., Gordon P.R., and Senf J.H. The variable response of women with menopausal hot flashes when treated with sertraline. Menopause 14 (2007) 1-5
148. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., and Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 62 (2005) 593-602 correction notice, 768
149. Kessler R.C., Chiu W.T., Jin R., Ruscio A.M., Shear K., and Walters E.E. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry 63 (2006) 415-424
150. Keyl P.M., and Eaton W.W. Risk factors for the onset of panic disorder and other panic attacks in a prospective, population-based study. American Journal of Epidemiology 131 2 (1990) 301-311
151. Kim Y.R., Min S.K., and Yu B.H. Differences in beta-adrenergic receptor sensitivity between women and men with panic disorder. European Neuropsychopharmacology 14 6 (2004) 515-520
152. Korhonen S., Saarijarvi S., and Aito M. Estradiol treatment of panic disorder in a fertile-aged woman. Human Psychopharmacology: Clinical and Experimental 10 6 (1995) 485-486
153. Kronenberg F. Hot flashes: Epidemiology and physiology. Annals of the New York Academy of Sciences 592 (1990) 52-86 discussion, 123-133
154. Kronenberg F., Cote L.J., Linkie D.M., Dyrenfurth I., and Downey J.A. Menopausal hot flashes: Thermoregulatory, cardiovascular, and circulating catecholamine and LH changes. Maturitas 6 1 (1984) 31-43
155. Krystal J.H., Woods S.W., Hill C.L., and Charney D.S. Characteristics of panic attacks subtypes: Assessment of spontaneous panic, situational panic, sleep panic, and limited symptom attacks. Comprehensive Psychiatry 32 (1991) 474-480
156. Kuh D.L., Wadsworth M., and Hardy R. Women's health in midlife: The influence of the menopause, social factors and health in earlier life. British Journal of Obstetrics & Gynaecology 104 (1997) 923-933
157. Kushner M.G., and Beitman B.D. Panic attacks without fear: An overview. Behaviour Research and Therapy 28 6 (1990) 469-479
158. Kushner M.G., Mackenzie T.B., Fiszdon J., Valentiner D.P., Foa E., Anderson N., et al. The effects of alcohol consumption on laboratory-induced panic and state anxiety. Archives of General Psychiatry 53 3 (1996) 264-270
159. Layton M.E., Friedman S.D., and Dager S.R. Brain metabolic changes during lactate-induced panic: Effects of gabapentin treatment. Depression and Anxiety 14 4 (2001) 251-254
160. Lee Y.J., Hohoff C., Domschke K., Sand P., Kuhlenbaumer G., Schirmacher A., et al. Norepinephrine transporter (NET) promoter and 5′-UTR polymorphisms: Association analysis in panic disorder. Neuroscience Letters 377 1 (2005) 40-43
161. Leen-Feldner E.W., Zvolensky M.J., van Lent J., Vujanovic A.A., Bleau T., Bernstein A., et al. Anxiety sensitivity moderates relations among tobacco smoking, panic attack symptoms, and bodily complaints in adolescents. Journal of Psychopathology and Behavioral Assessment 29 (2007) 69-79
162. LeLorier J., Gregoire G., Benhaddad A., Lapierre J., and Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. New England Journal of Medicine 337 (1997) 536-542
163. Le Melledo J.M., Jhangri G.S., Lott P., Tait G.R., McManus K., Geddes M., et al. Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder. Psychiatry Research 101 3 (2001) 237-242
164. Leonetti H.B., Longo S., and Anasti J.N. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstetrics & Gynecology 94 2 (1999) 225-228
165. Lepola U., Pollack M., Emilien G., Tzanis E., and Whitaker T. Venlafaxine XR and paroxetine in the short-term treatment of panic disorder. European Neuropsychopharmacology 13 (2003) S378
166. Lepola U.M., Wade A.G., Leinonen E.V., Koponen H.J., Frazer J., Sjodin I., et al. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder. Journal of Clinical Psychiatry 59 10 (1998) 528-534
167. 1A receptor-effector system responsivity in panic disorder. Psychopharmacology 106 (1992) 111-117
168. Li W., and Zinbarg R.E. Anxiety sensitivity and panic attacks: A 1-year longitudinal study. Behavior Modification 31 (2007) 145-161
169. Liebowitz M.R., Gorman J.M., Fyer A.J., Dillon D.J., and Klein D.F. Effects of naloxone on patients with panic attacks. American Journal of Psychiatry 141 8 (1984) 995-997
170. Lightman S.L., Jacobs H.S., Maguire A.K., McGarrick G., and Jeffcoate S.L. Climacteric flushing: Clinical and endocrine response to infusion of naloxone. British Journal of Obstetrics & Gynaecology 88 9 (1981) 919-924
171. Loprinzi C.L., Barton D., and Rummans T. Newer antidepressants inhibit hot flashes. Menopause: The Journal of the North American Menopause Society 13 4 (2006) 546-548
172. Maartens L.W., Leusink G.L., Knottnerus J.A., Smeets C.G., and Pop V.J. Climacteric complaints in the community. Family Practice 18 (2001) 189-194
173. MacLennan A.H., Broadbent J.L., Lester L., and Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. The Cochrane Database of Systematic Reviews 4 (2004) Art No. CD002978.pub002972. doi:002910.010002/14651858
174. A receptors: Relevance to the ovarian cycle and stress. Journal of Neuroscience 27 (2007) 2155-2162
175. Malacara J.M., Pérez-Luque E.L., Martínez-Garza S., and Sánchez-Marín F.J. The relationship of estrogen receptor-α polymorphism with symptoms and other characteristics in post-menopausal women. Maturitas 49 (2004) 163-169
176. Manson J.M., Sammel M.D., Wang Y., Freeman E.W., Hollander L., Liu L., et al. Modeling of longitudinal hormone data for predicting menopausal symptoms. Journal of Women's Health & Gender-Based Medicine 11 3 (2002) 325
177. Margraf J. Ambulatory psychophysiological monitoring of panic attacks. Journal of Psychophysiology 4 (1990) 321-330
178. Margraf J., Taylor B., Ehlers A., Roth W.T., and Agras W.S. Panic attacks in the natural environment. The Journal of Nervous and Mental Disease 175 (1987) 558-565
179. Martinez J.M., Kent J.M., Coplan J.D., Browne S.T., Papp L.A., Sullivan G.M., et al. Respiratory variability in panic disorder. Depression and Anxiety 14 4 (2001) 232-237
180. Mashchak C.A., Kletzky O.A., Artal R., and Mishell D.R. The relation of physiological changes to subjective symptoms in postmenopausal women with and without hot flushes. Maturitas 6 4 (1984) 301-308
181. Massana J., Risueño J.A., Masana G., Marcos T., Gonzalez L., and Otero A. Subtyping of panic disorder patients with bradycardia. European Psychiatry 16 (2001) 109-114
182. McCraty R., Atkinson M., Tomasino D., and Stuppy W.P. Analysis of twenty-four hour heart rate variability in patients with panic disorder. Biological Psychology 56 2 (2001) 131-150
183. McKinlay S.M., Brambilla D.J., and Posner J.G. The normal menopause transition. American Journal of Human Biology 4 1 (1992) 37-46
184. McKinlay S.M., and Jefferys M. The menopausal syndrome. British Journal of Preventive & Social Medicine 28 (1974) 108-115
185. McNally R.J. Anxiety sensitivity and panic disorder. Society of Biological Psychiatry 52 (2002) 938-946
186. McNally R.J., Hornig C.D., and Donnell C.D. Clinical versus nonclinical panic: A test of suffocation false alarm theory. Behaviour Research and Therapy 33 2 (1995) 127-131
187. Meldrum D.R., Defazio J.D., Erlik Y., Lu J.K., Wolfsen A.F., Carlson H.E., et al. Pituitary hormones during the menopausal hot flash. Obstetrics & Gynecology 64 6 (1984) 752-756
188. Meldrum D.R., Tataryn I.V., Frumar A.M., Erlik Y., Lu K.H., and Judd H.L. Gonadotropins, estrogens, and adrenal-steroids during the menopausal hot flash. Journal of Clinical Endocrinology & Metabolism 50 4 (1980) 685-689
189. Mendelson J.H., Lukas S.E., Mello N.K., Amass L., Ellingboe J., and Skupny A. Acute alcohol effects on plasma estradiol levels in women. Psychopharmacology 94 4 (1988) 464-467
190. Meuret A.E., White K.S., Ritz T., Roth W.T., Hofmann S.G., and Brown T.A. Panic attack symptom dimensions and their relationship to illness characteristics in panic disorder. Journal of Psychiatric Research 40 (2006) 520-527
191. Meuret A.E., Wilhelm F.H., Ritz T., and Roth W.T. Breathing training for treating panic disorder: Useful intervention or impediment?. Behavior Modification 27 5 (2003) 731-754
192. 2 as a therapeutic approach for panic disorder. Journal of Psychiatric Research
193. Michelson D., Lydiard R.B., Pollack M.H., Tamura R.N., Hoog S.L., Tepner R., et al. Outcome assessment and clinical improvement in panic disorder: Evidence from a randomized controlled trial of fluoxetine and placebo: The Fluoxetine Panic Disorder Study Group. American Journal of Psychiatry 155 11 (1998) 1570-1577
194. Miller H.G., and Li R.M. Measuring hot flashes: Summary of a National Institutes of Health workshop. Mayo Clinic Proceedings 79 (2004) 777-781
195. Mitroff I.I., and Featheringham T.R. On systematic problem solving and the error of the third kind. Behavioral Science 19 (1974) 383-393
196. Morrow J.D., McManus K., Tait G.R., Bellavance F., Chrapko W., Lara N., et al. Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: Effect of pretreatment with ethinyl estradiol. Journal of Psychiatry & Neuroscience 28 2 (2003) 127-133
197. National Institutes of Health. NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms: Program and abstract book (2005). http://consensus.nih.gov/ Retrieved August 1, 2005, from http://consensus.nih.gov/
198. Nedstrand E., Wijma K., Wyon Y., and Hammar M. Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Maturitas 51 2 (2005) 154-162
199. Nedstrand E., Wijma K., Wyon Y., and Hammar M. Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: A preliminary study. Climacteric 8 3 (2005) 243-250
200. Nelson H.D. Commonly used types of postmenopausal estrogen for treatment of hot flashes: Scientific review. JAMA: Journal of the American Medical Association 291 13 (2004) 1610-1620
201. Nelson H.D., Vesco K.K., Haney E., Fu R., Nedrow A., Miller J., et al. Nonhormonal therapies for menopausal hot flashes systematic review and meta-analysis. JAMA: Journal of the American Medical Association 295 17 (2006) 2057-2071
202. Neugarten B., and Kraines J. "Menopausal symptoms" in women of various ages. Psychosomatic Medicine 27 (1965) 266-273
203. The North American Menopause Society. Menopause practice: A clinician's guide (2004). http://www.menopause.org/edumaterials/cliniciansguide/ Retrieved August 6, 2005, from http://www.menopause.org/edumaterials/cliniciansguide/
204. Ohara K., Suzuki Y., Ochiai M., and Terada H. Polymorphism in the promoter region of the alpha (2A)-adrenergic receptor gene and panic disorders. Psychiatry Research 93 1 (2000) 79-82
205. Öst L. Applied relaxation versus progressive relaxation in the treatment of panic disorder. Behaviour Research and Therapy 26 1 (1988) 13-22
206. Pande A.C., Pollack M.H., Crockatt J., Greiner M., Chouinard G., Lydiard R.B., et al. Placebo-controlled study of gabapentin treatment of panic disorder. Journal of Clinical Psychopharmacology 20 4 (2000) 467-471
207. Perez D.G., Loprinzi C.L., Barton D.L., Pockaj B.A., Sloan J., Novotny P.J., et al. Pilot evaluation of mirtazapine for the treatment of hot flashes. The Journal of Supportive Oncology 2 1 (2004) 50-56
208. Pohl R.B., Wolkow R.M., and Clary C.M. Sertraline in the treatment of panic disorder: A double-blind multicenter trial. American Journal of Psychiatry 155 (1998) 1189-1195
209. Pollack M.H., Otto M.W., Worthington J.J., Manfro G.G., and Wolkow R. Sertraline in the treatment of panic disorder: A flexible-dose multicenter trial. Archives of General Psychiatry 55 (1998) 1010-1016
210. Pollack R.A., Carter A.S., Amir N., and Marks L.E. Anxiety sensitivity and auditory perception of heartbeat. Behaviour Research and Therapy 44 (2006) 1739-1756
211. Polo-Kantola P., Rauhala E., Saaresranta T., Aittokallio T., Erkkola R., and Polo O. Climacteric vasomotor symptoms do not predict nocturnal breathing abnormalities in postmenopausal women. Maturitas 39 (2001) 29-37
212. 2 challenge and risk for developing panic attacks: A controlled 6- and 12-month follow-up in a nonclinical sample. Journal of Anxiety Disorders 20 8 (2006) 1158-1167
213. Price W.A., and Heil D. Estrogen-induced panic attacks. Psychosomatics 29 4 (1988) 433-435
214. Radomsky A.S., Rachman S., and Hammond D. Panic termination and the post-panic period. Anxiety Disorders 16 (2002) 97-111
215. Raedler T.J., Holger J., Goedeken B., Gescher D.M., Kellner M., and Wiedemann K. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks. Depression and Anxiety 23 (2006) 139-144
216. Randolf J.F., Sowers M., Bondarenko I., Gold E.B., Greendale G.A., Bromberger J.T., et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopause transition. The Journal of Clinical Endocrinology & Metabolism 90 11 (2005) 6106-6112
217. Rapee R.M. Detection of somatic sensations in panic disorder. Behaviour Research and Therapy 32 (1994) 825-831
218. Reddy S.Y., Warner H., Guttuso T., Messing S., DiGrazio W., Thornburg L., et al. Gabapentin, estrogen, and placebo for treating hot flushes. Obstetrics & Gynecology 108 1 (2006) 41-48
219. Reed V., and Wittchen H.U. DSM-IV panic attacks and panic disorder in a community sample of adolescents and young adults: How specific are panic attacks?. Journal of Psychiatric Research 32 6 (1998) 335-345
220. Reynolds F. Perceived control over menopausal hot flushes: Exploring the correlates of a standardized measure. Maturitas 27 (1997) 215-221
221. Reynolds F. Psychological responses to menopausal hot flushes: Implications of a qualitative study for counseling interventions. Counseling Psychology Quarterly 10 3 (1997) 309-321
222. Reynolds F. Relationships between catastrophic thoughts, perceived control and distress during hot flushes: Exploring the correlates of a questionnaire measure. Maturitas 36 (2000) 113-122
223. Reynolds F. Exploring self-image during hot flushes using a semantic differential scale: Associations between poor self-image, depression, flush frequency and flush distress. Maturitas 42 (2002) 201-207
224. Richards J.C., Cooper A.J., and Winkleman J.H. Interoceptive accuracy in nonclinical panic. Cognitive Therapy and Research 27 (2003) 447-461
225. Rosano G.M.C., Patrizi R., Leonardo F., Ponikowski P., Collins P., Sarrel P.M., et al. Effect of estrogen replacement therapy on heart rate variability and heart rate in healthy menopausal women. The American Journal of Cardiology 80 (1997) 815-817
226. Sakai Y., Kumano H., Nishikawa M., Sakano Y., Kaiya H., Imabayashi E., et al. Cerebral glucose metabolism associated with a fear network in panic disorder. NeuroReport 16 (2005) 927-931
227. Sakai Y., Kumano H., Nishikawa M., Sakano Y., Kaiya H., Imabayashi E., et al. Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. NeuroImage 33 (2006) 218-226
228. Sand P.G., Mori T., Godau C., Stober G., Flachenecker P., Franke P., et al. Norepinephrine transporter gene (NET) variants in patients with panic disorder. Neuroscience Letters 333 1 (2002) 41-44
229. Sand P.G., Schlurmann K., Luckhaus C., Gotz M., Stober G., Lesch K.P., et al. Estrogen receptor 1 gene (ESR1) variants in panic disorder. American Journal of Medical Genetics 114 4 (2002) 426-428
230. Sanderson W.C., Rapee R.M., and Barlow D.H. The influence of an illusion of control on panic attacks induced via 5.5% carbon dioxide-enriched air. Archives of General Psychiatry 46 (1989) 157-162
231. Santoro N., Brockwell S., Johnston J., Crawford S.L., Gold E.B., Harlow S.D., et al. Helping midlife women predict the onset of the final menses: SWAN, the Study of Women's Health Across the Nation. Menopause 14 (2007) 415-424
232. Sarchiapone M., Amore M., De Risio S., Carli V., Faia V., Poterzio F., et al. Mirtazapine in the treatment of panic disorder: An open-label trial. International Clinical Psychopharmacology 18 1 (2003) 35-38
233. Schiff I., Tulchinsky D., Cramer D., and Ryan K.J. Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA: Journal of the American Medical Association 244 13 (1980) 1443-1445
234. Schmidt N.B., Forsyth J.P., Santiago H.T., and Trakowski J.H. Classification of panic attack subtypes in patients and normal controls in response to biological challenge: Implications for assessment and treatment. Anxiety Disorders 16 (2002) 625-638
235. Schmidt N.B., Lerew D.R., and Jackson R.J. Prospective evaluation of anxiety sensitivity in the pathogenesis of panic: Replication and extension. Journal of Abnormal Psychology 108 (1999) 532-537
236. Schmidt N.B., Richey J.A., and Fitzpatrick K.K. Discomfort intolerance: Development of a construct and measure relevant to panic disorder. Journal of Anxiety Disorders 20 3 (2006) 263-280
237. Schmidt N.B., Zvolensky M.J., and Maner J.K. Anxiety sensitivity: Prospective prediction of panic attacks and axis I pathology. Journal of Psychiatric Research 40 (2006) 691-699
238. Schruers K.R.J., van de Mortel H., Overbeek T., and Griez E. Symptom profiles of natural and laboratory panic attacks. Acta Neuropsychiatrica 16 (2004) 101-106
239. Schunck T., Erb G., Mathis A., Gilles C., Namer I.J., Hode Y., et al. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety. NeuroImaging 31 (2006) 1197-1208
240. Sestak I., Kealy R., Edwards R., Forbes J., and Cuzick J. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms. Journal of Clinical Oncology 24 24 (2006) 3991-3996
241. Shear M.K., Brown T.A., Barlow D.H., Money R., Sholomskas D.E., Woods S.W., et al. Multicenter collaborative panic disorder severity scale. American Journal of Psychiatry 154 (1997) 1571-1575
242. Simpkins J.W., Katovich M.J., and Song I.C. Similarities between morphine withdrawal in the rat and the menopausal hot flush. Life Sciences 32 17 (1983) 1957-1966
243. Sinha S.S., Goetz R.R., and Klein D.F. Physiological and behavioral effects of naloxone and lactate in normals with relevance to the pathophysiology of panic disorder. Psychiatry Research 149 (2007) 309-314
244. Slaap B.R., Nielen M.M.A., Boshuisen M.L., van Roon A.M., and den Boer J.A. Five-minute recordings of heart rate variability in obsessive-compulsive disorder, panic disorder and healthy volunteers. Journal of Affective Disorders 78 2 (2004) 141-148
245. Slade P., and Amaee S. The role of anxiety and temperature in the experience of menopausal hot flushes. Journal of Reproductive and Infant Psychology 13 (1995) 127-134
246. Smoller J.W., Pollack M.H., Wassertheil-Smoller S., Barton B., Hendrix S.L., Jackson R.D., et al. Prevalence and correlates of panic attacks in postmenopausal women: Results from an ancillary study to the women's health initiative. Archives of Internal Medicine 163 17 (2003) 2041-2050
247. Soules M.R., Sherman S., Parrott E., Rebar R., Santoro N., Utian W., et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Journal of Women's Health & Gender-Based Medicine 10 9 (2001) 843-848
248. Street L.L., Craske M.G., and Barlow D.H. Sensations, cognitions, and the perception of cues associated with expected and unexpected panic attacks. Behaviour Research and Therapy 27 (1989) 189-198
249. Strohle A., Romeo E., di Michele F., Pasini A., Hermann B., Gajewsky G., et al. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: Preliminary results. Archives of General Psychiatry 60 2 (2003) 161-168
250. Strohle A., Romeo E., di Michele F., Pasini A., Yassouridis A., Holsboer F., et al. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. American Journal of Psychiatry 159 1 (2002) 145-147
251. Sturdee D.W., Wilson K.A., Pipili E., and Crocker A.D. Physiological aspects of menopausal hot flush. British Medical Journal 2 (1978) 79-80
252. Suvanto-Luukkonen E., Koivunen R., Sundstrom H., Bloigu R., Kaljalainen E., Haiva-Mallinen L., et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: A prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause: The Journal of the North American Menopause Society 12 1 (2005) 18-26
253. Swartzman L.C., Edelberg R., and Kemmann E. Impact of stress on objectively recorded menopausal hot flushes and on flush report bias. Health Psychology 9 5 (1990) 529-545
254. Swartzman L.C., Edelberg R., and Kemmann E. The menopausal hot flush: Symptom reports and concomitant physiological changes. Journal of Behavioral Medicine 13 1 (1990) 15-30
255. Tait G.R., McManus K., Bellavance F., Lara N., Chrapko W., and Le Melledo J.M. Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin. Psychoneuroendocrinology 27 4 (2002) 417-429
256. Tataryn I.V., Lomax P., Bajorek J.G., Chesarek W., Meldrum D.R., and Judd H.L. Postmenopausal hot flushes: A disorder of thermoregulation. Maturitas 2 (1980) 101-107
257. Tataryn I.V., Lomax P., Meldrum D.R., Bajorek J.G., Chesarek W., and Judd H.L. Objective techniques for the assessment of postmenopausal hot flashes. Obstetrics & Gynecology 57 3 (1981) 340-344
258. Taylor C.B., Sheikh J., Agras W.S., Roth R.T., Margraf J., Ehlers A., et al. Ambulatory heart rate changes in patients with panic attacks. American Journal of Psychiatry 143 (1986) 478-482
259. Telch M.J., Lucas J.A., and Nelson P. Nonclinical panic in college-students: An investigation of prevalence and symptomatology. Journal of Abnormal Psychology 98 3 (1989) 300-306
260. Tepper R., Neri A., Kaufman H., Schoenfeld A., and Ovadia J. Menopausal hot flushes and plasma beta-endorphins. Obstetrics & Gynecology 70 2 (1987) 150-152
261. Thurston R.C., Blumenthal J.A., Babyak M.A., and Sherwood A. Emotional antecedents of hot flashes during daily life. Psychosomatic Medicine 67 1 (2005) 137-146
262. Tulandi T., Kinch R.A., Guyda H., Maiolo L.M., and Lal S. Effect of naloxone on menopausal flushes, skin temperature, and luteinizing hormone secretion. American Journal of Obstetrics & Gynecology 151 2 (1985) 277-280
263. Uhlenhuth E.H., Leon A.C., and Matuzas W. Psychopathology of panic attacks in panic disorder. Journal of Affective Disorders 92 (2006) 55-62
264. Uhlenhuth E.H., Matuzas W., Warner T.D., Paine S., Lydiard R.B., and Pollack M.H. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication. Journal of Clinical Psychopharmacology 20 6 (2000) 622-627
265. Valenca A.M., Nardi A.E., Mezzasalma M.A., Nascimento I., Lopes F.L., Zin W.A., et al. Clonidine in respiratory panic disorder subtype. Arquivos De Neuro-Psiquiatria 62 2B (2004) 396-398
266. van der Feltz-Cornelis C.M. Hot flashes resistant to hormone replacement in menopausal women: Panic disorder?. Nederlands Tijdschrift voor Geneeskunde 143 6 (1999) 281-284
267. Versiani M., Cassano G., Perugi G., Benedetti A., Mastalli L., Nardi A., et al. Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. Journal of Clinical Psychiatry 63 1 (2002) 31-37
268. Virtanen I., Polo-Kantola P., Erkkola R., Polo O., and Ekholm E. Climacteric vasomotor symptoms do not imply autonomic dysfunction. British Journal of Obstetrics & Gynaecology 106 (1999) 155-164
269. Visvanathan K., Gallicchio L., Schilling C., Babus J.K., Lewis L.M., Miller S.R., et al. Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women. Obstetrics & Gynecology 106 6 (2005) 1372-1381
270. Voda A.M. Climacteric hot flash. Maturitas 3 (1981) 73-90
271. Wade A.G., Lepola U., Koponen H.J., Pedersen V., and Pedersen T. The effect of citalopram in panic disorder. British Journal of Psychiatry 170 (1997) 549-553
272. Weiss G., Skurnick J.H., Goldsmith L.T., Santoro N.F., and Park S.J. Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA: Journal of the American Medical Association 292 24 (2004) 2991-2996
273. Westen D., and Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: An empirical examination of the status of empirically supported therapies. Journal Of Consulting and Clinical Psychology 69 (2001) 875-899
274. Whiteman M.K., Staropoli C.A., Langenberg P.W., McCarter R.J., Kjerulff K.H., and Flaws J.A. Smoking, body mass, and hot flashes in midlife women. Obstetrics & Gynecology 101 (2003) 264-272
275. Wijma K., Melin A., Nedstrand E., and Hammar M. Treatment of menopausal symptoms with applied relaxation: A pilot study. Journal of Behavior Therapy & Experimental Psychiatry 28 4 (1997) 251-261
276. Wilhelm F.H., Trabert W., and Roth W.T. Physiologic instability in panic disorder and generalized anxiety disorder. Society of Biological Psychiatry 49 (2001) 596-605
277. Wilkinson D.J.C., Thompson J.M., Lambert G.W., Jennings G.L., Schwarz R.G., Jefferys D., et al. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Archives of General Psychiatry 55 6 (1998) 511-520
278. Wilson K.G., Sandler L.S., Asmundson G.J.G., Ediger J.M., Larsen D.K., and Walker J.R. Panic attacks in the nonclinical population: An empirical approach to case identification. Journal of Abnormal Psychology 101 3 (1992) 460-468
279. Windham G.C., Elkin E., Swan S.H., Waller K.D., and Fenster L. Cigarette smoking and effects on menstrual function. Obstetrics & Gynecology 93 (1999) 59-65
280. Windham G.C., Mitchell P., Anderson M., and Lasley B.L. Cigarette smoking and effects on hormone function in premenopausal women. Environmental Health Perspectives 113 10 (2005) 1285-1290
281. Wisner K.L., Peindl K.S., and Hanusa B.H. Effects of childbearing on the natural history of panic disorder with comorbid mood disorder. Journal of Affective Disorders 41 3 (1996) 173-180
282. Wolf R., Tüzün B., and Tüzün Y. Alcohol ingestion and the cutaneous vasculature. Clinics in Dermatology 17 (1999) 395-403
283. Woods N.F., Mitchell E.S., Tao Y., Viernes H.A., Stapleton P.L., and Farin F.M. Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: Observations from the Seattle Midlife Women's Health Study. Menopause 13 (2006) 902-910
284. Woodward S., Greville H.W., and Freedman R.R. Ventilatory response during menopausal hot flashes. Menopause: The Journal of the North American Menopause Society 2 2 (1995) 81-88
285. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Initiative randomized controlled trial. JAMA: Journal of the American Medical Association 288 (2002) 321-333
286. Yeragani V.K., Mallavarapu M., Radhakrishna R.K.A., Tancer M., and Uhde T. Linear and nonlinear measures of blood pressure variability: Increased chaos of blood pressure time series in patients with panic disorder. Depression and Anxiety 19 2 (2004) 85-95
287. Yoda T., Crawshaw L.I., Nakamura M., Saito K., Konishi A., Nagashima K., et al. Effects of alcohol on thermoregulation during mild heat exposure in humans. Alcohol 36 (2005) 195-200
288. Yonkers K.A., Bruce S.E., Dyck I.R., and Keller M.B. Chronicity, relapse, and illness: Course of panic disorder, social phobia, and generalized anxiety disorder: Findings in men and women from 8 years of follow-up. Depression and Anxiety 17 3 (2003) 173-179
289. Zoellner L.A., and Craske M.G. Interoceptive accuracy and panic. Behaviour Research and Therapy 37 (1999) 1141-1158
290. Zvolenksy M.J., Kotov R., Antipova A.V., and Schmidt N.B. Diathesis stress model for panic-related distress: A test in a Russian epidemiological sample. Behaviour Research and Therapy 43 (2005) 521-532
291. Zvolenksy M.J., Sachs-Ericsson N., Feldner M.T., Schmidt N.B., and Bowman C.J. Neuroticism moderates the effect of maximum smoking level on lifetime panic disorder: A test using an epidemiologically defined national sample of smokers. Psychiatry Research 141 (2006) 321-332